Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multidisciplinary management of lung cancer.

× No keyword cloud information.

258 in total

1. Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy.

Authors: Yafei Li; Zhifu Sun; Julie M Cunningham; Marie C Aubry; Jason A Wampfler; Gary A Croghan; Cassandra Johnson; Danli Wu; Jeremiah A Aakre; Julian Molina; Liewei Wang; V Shane Pankratz; Ping Yang
Journal: Clin Cancer Res Date: 2011-06-01 Impact factor: 12.531

2. ERCC1 expression as a prognostic and predictive factor in patients with non-small cell lung cancer: a meta-analysis.

Authors: Jingwei Jiang; Xiaohua Liang; Xinli Zhou; Ruofan Huang; Zhaohui Chu; Qiong Zhan
Journal: Mol Biol Rep Date: 2012-06 Impact factor: 2.316

3. Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer.

Authors: Hao Zhang; Kristen Wroblewski; Daniel Appelbaum; Yonglin Pu
Journal: Int J Comput Assist Radiol Surg Date: 2012-05-30 Impact factor: 2.924

4. Clinical significance of coexpression of L-type amino acid transporter 1 (LAT1) and ASC amino acid transporter 2 (ASCT2) in lung adenocarcinoma.

Authors: Tomohiro Yazawa; Kimihiro Shimizu; Kyoichi Kaira; Toshiteru Nagashima; Yoichi Ohtaki; Jun Atsumi; Kai Obayashi; Shushi Nagamori; Yoshikatsu Kanai; Tetsunari Oyama; Izumi Takeyoshi
Journal: Am J Transl Res Date: 2015-06-15 Impact factor: 4.060

5. Radiotherapy Planning Complexity and Survival after Treatment of Advanced Stage Lung Cancer in the Elderly.

Authors: Benjamin Goldsmith; Jamie Cesaretti; Juan P Wisnivesky
Journal: Cancer Date: 2009-10-15 Impact factor: 6.860

6. Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling.

Authors: Yasushi Shintani; Masato Maeda; Nina Chaika; Keith R Johnson; Margaret J Wheelock
Journal: Am J Respir Cell Mol Biol Date: 2007-08-02 Impact factor: 6.914

Review 7. Second-line Therapy for advanced non-small-cell lung cancer.

Authors: Christine L Hann; Julie R Brahmer
Journal: Curr Oncol Rep Date: 2006-07 Impact factor: 5.075

8. Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma.

Authors: Xinwei Yun; Keqiang Zhang; Jinhui Wang; Rajendra P Pangeni; Lu Yang; Melissa Bonner; Jun Wu; Jami Wang; Isaac K Nardi; Ming Gao; Dan J Raz
Journal: Mol Cancer Res Date: 2018-05-02 Impact factor: 5.852

Review 9. The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications.

Authors: Lei Wu; Lili Yang
Journal: Oncol Lett Date: 2018-03-08 Impact factor: 2.967

10. Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth.

Authors: Hua Zhong; Baohui Han; Irina L Tourkova; Anna Lokshin; Alan Rosenbloom; Michael R Shurin; Galina V Shurin
Journal: Clin Cancer Res Date: 2007-09-15 Impact factor: 12.531